Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Business / Vivani Medical Board Changes
Business board changes

Vivani Medical Board Changes

Analysis based on 6 articles · First reported Jun 26, 2026 · Last updated Jun 26, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The appointment of August Moretti to the board of Vivani Medical is likely to be viewed positively by the market, as his extensive financial and operational experience could strengthen the company's strategic direction and financial oversight. This could lead to a slight positive sentiment for Vivani Medical's stock. The retirement of Dr. Daniel Baker is a planned transition and is not expected to have a significant negative impact.

biopharmaceutical
Event Summary

Vivani Medical, a clinical-stage biopharmaceutical company, announced significant changes to its board of directors. August Moretti was appointed to the board, bringing with him extensive experience as a financial and operating executive from companies such as 4D Molecular Therapeutics, Assertio Holdings, and Alexza Pharmaceuticals. He will serve as the chair of the Audit Committee and a member of the Compensation Committee. Concurrently, Dr. Daniel Baker retired from the board after a distinguished tenure, during which he provided crucial guidance, including during the merger of Praxis Precision Medicines and Argus retinal prosthesis. Gregg Williams, Chairman of the Board, expressed enthusiasm for August Moretti's expertise and gratitude for Dr. Daniel Baker's contributions, emphasizing the importance of these changes as Vivani Medical advances its lead semaglutide implant, NPM-139, through clinical development.

Entities Involved
priv
Vivani Medical
Vivani Medical announced the appointment of August Moretti to its board of directors and the retirement of Dr. Daniel Baker. This change is expected to bring new expertise to the company as it advances its clinical-stage drug implants.
Importance 100.0 Sentiment 10.0
per
August Moretti
August Moretti was appointed to the board of directors of Vivani Medical, bringing extensive operating and financial executive experience. He will chair the Audit Committee and serve on the Compensation Committee, which is expected to benefit Vivani Medical's strategic and financial oversight.
Importance 90.0 Sentiment 20.0
per
Daniel Baker
Dr. Daniel Baker retired from the board of directors of Vivani Medical after a distinguished tenure, during which he provided critical guidance, including during the merger of Praxis Precision Medicines and Argus retinal prosthesis.
Importance 50.0 Sentiment 0.0
per
Gregg Williams
Gregg Williams, Chairman of the Board of Vivani Medical, welcomed August Moretti and thanked Dr. Daniel Baker for his service, highlighting the importance of these board changes for Vivani Medical's future.
Importance 30.0 Sentiment 0.0
priv
Argus retinal prosthesis
Dr. Daniel Baker provided critical guidance during the merger of Praxis Precision Medicines and Argus retinal prosthesis, which led to the formation of Vivani Medical.
Importance 20.0 Sentiment 0.0
stock
Praxis Precision Medicines
Dr. Daniel Baker provided critical guidance during the merger of Praxis Precision Medicines and Argus retinal prosthesis, which led to the formation of Vivani Medical.
Importance 20.0 Sentiment 0.0
stock
Assertio Holdings
August Moretti previously served as the CFO of Assertio Holdings, contributing to his extensive financial executive experience.
Importance 10.0 Sentiment 0.0
stock
Alexza Pharmaceuticals
August Moretti held CFO and General Counsel roles at Alexza Pharmaceuticals, further demonstrating his experience in the life science sector.
Importance 10.0 Sentiment 0.0
priv
Cibus
August Moretti currently serves as a member of the Board and chair of the Audit Committee for Cibus, Inc., indicating his ongoing involvement in corporate governance.
Importance 10.0 Sentiment 0.0
stock
4D Molecular Therapeutics
August Moretti previously served as the Chief Financial Officer of 4D Molecular Therapeutics, providing him with relevant experience for his new role at Vivani Medical.
Importance 10.0 Sentiment 0.0
priv
Ferrer International
Alexza Pharmaceuticals was acquired by Ferrer International, which is mentioned in the context of August Moretti's past roles.
Importance 5.0 Sentiment 0.0
oth
Alavita
August Moretti held CFO and General Counsel roles at Alavita, Inc., adding to his diverse experience.
Importance 5.0 Sentiment 0.0
oth
Heller Ehrman
August Moretti was a partner at Heller Ehrman, where he represented life science companies in various financial and legal matters.
Importance 5.0 Sentiment 0.0
subs
Sonova — Sonova
Dr. Daniel Baker's career includes senior leadership roles at Sonova — Sonova.
Importance 5.0 Sentiment 0.0
oth
Alfred E. Mann Institute for Biomedical Engineering
Dr. Daniel Baker's career includes senior leadership roles at the Alfred E. Mann Institute for Biomedical Engineering.
Importance 5.0 Sentiment 0.0
+ 1 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.